2014
DOI: 10.1016/j.yexmp.2014.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Ac-SDKP suppresses epithelial–mesenchymal transition in A549 cells via HSP27 signaling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 32 publications
0
13
0
Order By: Relevance
“…Accordingly, it was previously demonstrated that Ac-SDKP can inhibit the myofibroblast differentiation of human fetal lung fibroblasts (MRC-5) cells induced by Ang II [24]. Furthermore, it was shown that Ac-SDKP suppresses epithelial-mesenchymal transition in A549 cells via HSP27 signaling [25]. Since effective IPF therapies should be focused on halting the fibroblast/myofibroblast differentiation process, and consequently abnormal tissue remodeling as well as excessive accumulation of extracellular matrix, we propose Ac-SDKP as a valid putative drug for lung fibrosis.…”
Section: Discussionmentioning
confidence: 99%
“…Accordingly, it was previously demonstrated that Ac-SDKP can inhibit the myofibroblast differentiation of human fetal lung fibroblasts (MRC-5) cells induced by Ang II [24]. Furthermore, it was shown that Ac-SDKP suppresses epithelial-mesenchymal transition in A549 cells via HSP27 signaling [25]. Since effective IPF therapies should be focused on halting the fibroblast/myofibroblast differentiation process, and consequently abnormal tissue remodeling as well as excessive accumulation of extracellular matrix, we propose Ac-SDKP as a valid putative drug for lung fibrosis.…”
Section: Discussionmentioning
confidence: 99%
“…In vitro experiments have also demonstrated inhibition of epithelial-to-mesenchymal transition in tissue culture [29]. Mineralocorticoid receptor antagonists have been demonstrated to modulate Gal-3 expression after acute myocardial infarction [30] and to prevent aldosterone-salt induced cardiac hypertrophy, dysfunction, and fibrosis [31].…”
Section: Discussionmentioning
confidence: 99%
“…Type I and III collagen are essential ECM components that reflect the differentiation extent of myofibroblasts (40)(41)(42)(43). In our previous studies, we found that 5 ng/ml TGF-β1 was able to successfully induce the transition of A549 human alveolar type II epithelial cells to myofibroblasts, accompanied with upregulation of type I and III collagen expression (13). In A549 cells transfected with HSP27-interfering plasmid, the expression of type I and III collagen was downregulated by TGF-β1 stimulation, which suggested that HSP27 is a factor that may induce fibrosis in the transition of TGF-β1-induced A549 human alveolar type II epithelial cells to myofibroblasts.…”
Section: Discussionmentioning
confidence: 93%
“…Transforming growth factor-β1 (TGF-β1) is an important transforming growth factor associated with fibrosis in vitro and in vivo (11,12). A previous study by the authors revealed that TGF-β1 may induce A549 human alveolar type II epithelial cells to differentiate into myofibroblasts (13). In order to investigate the effect of HSP27 on the differentiation of A549 human alveolar type II epithelial cell line into myofibroblasts and collagen synthesis, the current study used liposome transfection to transfect A549 human alveolar type II epithelial cell line and determined the optimal liposome:plasmid ratio and the best interference sequence.…”
Section: Introductionmentioning
confidence: 99%